img

Global Injectable Sumatriptan Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 95 | Industry : Pharma & Healthcare

Publisher : q | Format : PDF

Global Injectable Sumatriptan Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
4mg
6mg
Others


Segment by Application


Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


GlaxoSmithKline
Pfizer
Teva
Sun Pharma

Table of Content

1 Injectable Sumatriptan Market Overview
1.1 Product Overview and Scope of Injectable Sumatriptan
1.2 Injectable Sumatriptan Segment by Type
1.2.1 Global Injectable Sumatriptan Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 4mg
1.2.3 6mg
1.2.4 Others
1.3 Injectable Sumatriptan Segment by Application
1.3.1 Injectable Sumatriptan Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Injectable Sumatriptan Market Size Estimates and Forecasts
1.4.1 Global Injectable Sumatriptan Revenue 2016-2027
1.4.2 Global Injectable Sumatriptan Sales 2016-2027
1.4.3 Injectable Sumatriptan Market Size by Region: 2016 Versus 2021 Versus 2027

2 Injectable Sumatriptan Market Competition by Manufacturers
2.1 Global Injectable Sumatriptan Sales Market Share by Manufacturers (2016-2021)
2.2 Global Injectable Sumatriptan Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Injectable Sumatriptan Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Injectable Sumatriptan Manufacturing Sites, Area Served, Product Type
2.5 Injectable Sumatriptan Market Competitive Situation and Trends
2.5.1 Injectable Sumatriptan Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Injectable Sumatriptan Players Market Share by Revenue
2.5.3 Global Injectable Sumatriptan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Sumatriptan Retrospective Market Scenario by Region
3.1 Global Injectable Sumatriptan Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Injectable Sumatriptan Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Injectable Sumatriptan Market Facts & Figures by Country
3.3.1 North America Injectable Sumatriptan Sales by Country
3.3.2 North America Injectable Sumatriptan Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Injectable Sumatriptan Market Facts & Figures by Country
3.4.1 Europe Injectable Sumatriptan Sales by Country
3.4.2 Europe Injectable Sumatriptan Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Injectable Sumatriptan Market Facts & Figures by Region
3.5.1 Asia Pacific Injectable Sumatriptan Sales by Region
3.5.2 Asia Pacific Injectable Sumatriptan Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Injectable Sumatriptan Market Facts & Figures by Country
3.6.1 Latin America Injectable Sumatriptan Sales by Country
3.6.2 Latin America Injectable Sumatriptan Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Injectable Sumatriptan Market Facts & Figures by Country
3.7.1 Middle East and Africa Injectable Sumatriptan Sales by Country
3.7.2 Middle East and Africa Injectable Sumatriptan Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Injectable Sumatriptan Historic Market Analysis by Type
4.1 Global Injectable Sumatriptan Sales Market Share by Type (2016-2021)
4.2 Global Injectable Sumatriptan Revenue Market Share by Type (2016-2021)
4.3 Global Injectable Sumatriptan Price by Type (2016-2021)

5 Global Injectable Sumatriptan Historic Market Analysis by Application
5.1 Global Injectable Sumatriptan Sales Market Share by Application (2016-2021)
5.2 Global Injectable Sumatriptan Revenue Market Share by Application (2016-2021)
5.3 Global Injectable Sumatriptan Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Injectable Sumatriptan Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Injectable Sumatriptan Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Injectable Sumatriptan Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sun Pharma Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates

7 Injectable Sumatriptan Manufacturing Cost Analysis
7.1 Injectable Sumatriptan Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Injectable Sumatriptan
7.4 Injectable Sumatriptan Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Injectable Sumatriptan Distributors List
8.3 Injectable Sumatriptan Customers

9 Injectable Sumatriptan Market Dynamics
9.1 Injectable Sumatriptan Industry Trends
9.2 Injectable Sumatriptan Growth Drivers
9.3 Injectable Sumatriptan Market Challenges
9.4 Injectable Sumatriptan Market Restraints

10 Global Market Forecast
10.1 Injectable Sumatriptan Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Injectable Sumatriptan by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Injectable Sumatriptan by Type (2022-2027)
10.2 Injectable Sumatriptan Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Injectable Sumatriptan by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Injectable Sumatriptan by Application (2022-2027)
10.3 Injectable Sumatriptan Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Injectable Sumatriptan by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Injectable Sumatriptan by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Injectable Sumatriptan Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Injectable Sumatriptan Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Injectable Sumatriptan Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Injectable Sumatriptan Covered in This Study
Table 5. Global Injectable Sumatriptan Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Injectable Sumatriptan Sales Share by Manufacturers (2016-2021)
Table 7. Global Injectable Sumatriptan Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Injectable Sumatriptan Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Injectable Sumatriptan Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Injectable Sumatriptan Manufacturing Sites and Area Served
Table 11. Manufacturers Injectable Sumatriptan Product Type
Table 12. Global Injectable Sumatriptan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Injectable Sumatriptan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Sumatriptan as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Injectable Sumatriptan Sales by Region (2016-2021) & (K Units)
Table 16. Global Injectable Sumatriptan Sales Market Share by Region (2016-2021)
Table 17. Global Injectable Sumatriptan Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 19. North America Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 20. North America Injectable Sumatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 22. Europe Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 23. Europe Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 24. Europe Injectable Sumatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Injectable Sumatriptan Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Injectable Sumatriptan Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Injectable Sumatriptan Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Injectable Sumatriptan Revenue Market Share by Region (2016-2021)
Table 30. Latin America Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 32. Latin America Injectable Sumatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Injectable Sumatriptan Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Injectable Sumatriptan Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Injectable Sumatriptan Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Injectable Sumatriptan Revenue Market Share by Country (2016-2021)
Table 38. Global Injectable Sumatriptan Sales (K Units) by Type (2016-2021)
Table 39. Global Injectable Sumatriptan Sales Market Share by Type (2016-2021)
Table 40. Global Injectable Sumatriptan Revenue (Million US$) by Type (2016-2021)
Table 41. Global Injectable Sumatriptan Revenue Share by Type (2016-2021)
Table 42. Global Injectable Sumatriptan Price (US$/Unit) by Type (2016-2021)
Table 43. Global Injectable Sumatriptan Sales (K Units) by Application (2016-2021)
Table 44. Global Injectable Sumatriptan Sales Market Share by Application (2016-2021)
Table 45. Global Injectable Sumatriptan Revenue (Million US$) by Application (2016-2021)
Table 46. Global Injectable Sumatriptan Revenue Share by Application (2016-2021)
Table 47. Global Injectable Sumatriptan Price (US$/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Injectable Sumatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Injectable Sumatriptan Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Injectable Sumatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer Injectable Sumatriptan Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Teva Corporation Information
Table 59. Teva Description and Business Overview
Table 60. Teva Injectable Sumatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Teva Injectable Sumatriptan Product
Table 62. Teva Recent Developments/Updates
Table 63. Sun Pharma Corporation Information
Table 64. Sun Pharma Description and Business Overview
Table 65. Sun Pharma Injectable Sumatriptan Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sun Pharma Injectable Sumatriptan Product
Table 67. Sun Pharma Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Injectable Sumatriptan Distributors List
Table 71. Injectable Sumatriptan Customers List
Table 72. Injectable Sumatriptan Market Trends
Table 73. Injectable Sumatriptan Growth Drivers
Table 74. Injectable Sumatriptan Market Restraints
Table 75. Global Injectable Sumatriptan Sales Forecast by Type (2022-2027) & (K Units)
Table 76. Global Injectable Sumatriptan Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Injectable Sumatriptan Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Injectable Sumatriptan Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Injectable Sumatriptan Sales Forecast by Application (2022-2027) & (K Units)
Table 80. Global Injectable Sumatriptan Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Injectable Sumatriptan Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Injectable Sumatriptan Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Injectable Sumatriptan Sales Forecast by Region (2022-2027) & (K Units)
Table 84. Global Injectable Sumatriptan Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Injectable Sumatriptan Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Injectable Sumatriptan Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injectable Sumatriptan
Figure 2. Global Injectable Sumatriptan Market Share by Type in 2020 & 2027
Figure 3. 4mg Product Picture
Figure 4. 6mg Product Picture
Figure 5. Others Product Picture
Figure 6. Global Injectable Sumatriptan Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Global Injectable Sumatriptan Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Injectable Sumatriptan Market Size 2016-2027 (US$ Million)
Figure 12. Global Injectable Sumatriptan Sales 2016-2027 (K Units)
Figure 13. Global Injectable Sumatriptan Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Injectable Sumatriptan Sales Share by Manufacturers in 2020
Figure 15. Global Injectable Sumatriptan Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Injectable Sumatriptan Players: Market Share by Revenue in 2020
Figure 17. Injectable Sumatriptan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Injectable Sumatriptan Sales Market Share by Region (2016-2021)
Figure 19. Global Injectable Sumatriptan Sales Market Share by Region in 2020
Figure 20. Global Injectable Sumatriptan Revenue Market Share by Region (2016-2021)
Figure 21. Global Injectable Sumatriptan Revenue Market Share by Region in 2020
Figure 22. U.S. Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Injectable Sumatriptan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Injectable Sumatriptan by Type (2016-2021)
Figure 47. Sales Market Share of Injectable Sumatriptan by Application (2016-2021)
Figure 48. Sales Market Share of Injectable Sumatriptan by Application in 2020
Figure 49. Revenue Share of Injectable Sumatriptan by Application (2016-2021)
Figure 50. Revenue Share of Injectable Sumatriptan by Application in 2020
Figure 51. Manufacturing Cost Structure of Injectable Sumatriptan
Figure 52. Manufacturing Process Analysis of Injectable Sumatriptan
Figure 53. Injectable Sumatriptan Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed